Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Total Liabilities (2016 - 2025)

Macrogenics (MGNX) has disclosed Total Liabilities for 14 consecutive years, with $201.3 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 38.23% to $201.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $201.3 million through Dec 2025, up 38.23% year-over-year, with the annual reading at $201.3 million for FY2025, 38.23% up from the prior year.
  • Total Liabilities for Q4 2025 was $201.3 million at Macrogenics, down from $203.8 million in the prior quarter.
  • The five-year high for Total Liabilities was $234.2 million in Q1 2023, with the low at $72.4 million in Q3 2022.
  • Average Total Liabilities over 5 years is $137.6 million, with a median of $142.7 million recorded in 2024.
  • The sharpest move saw Total Liabilities soared 151.24% in 2023, then crashed 39.32% in 2024.
  • Over 5 years, Total Liabilities stood at $95.6 million in 2021, then skyrocketed by 44.79% to $138.5 million in 2022, then grew by 5.31% to $145.8 million in 2023, then fell by 0.14% to $145.6 million in 2024, then skyrocketed by 38.23% to $201.3 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $201.3 million, $203.8 million, and $198.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.